CClinicalTrials.gg
CompletedNCT06682091MOCOMIUpdated Nov 12, 2024

Management and Outcome of Mesh Infection After Abdominoplasty in a Tertiary Care Centre

An observational study in Abdominal Infection, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-12.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
209
Ages
18 Years and older
Sex
All
01

Study summary

Hernia repair is among most frequent surgical interventions. The use of abdominal mesh in hernia repair has become the Gold Standard strategy, reducing the risk of relapse.

The mesh infection risk is estimated lower than 1% in simple situations, but can increase up to 20% in complicated patients. Risk factors are well known, but we lack data regarding the therapeutic strategies and outcomes.

This study aims to describe the characteristics and management of abdominal mesh infections, and the related outcomes.

02

Conditions studied

  • Abdominal Infection

Keywords

  • mesh infection
  • abdominoplasty
03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's enrollment of 209 is below the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects taken in care for abdominal mesh infection in the Hospices Civils de Lyon from 2010 to 2023.

Inclusion criteria

  • parietal mesh infection
  • age > 18

Exclusion criteria

Exclusion Criteria:

  • Non French speaking patients.
  • Persons under tutorship or curatorship.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
209 participants (actual)
Patient registry
No

Groups and cohorts

  • Cohort of patients admitted for an abdominal mesh infection at Hospices Civils de Lyon

    No intervention. Retrospective data collection.

06

What researchers measure

Primary outcomes

  1. Treatment failure.

    Clinical failure = persistance of the infection. Time of failure is the time of change of therapeutic strategy.

    Time frame: Retrospective analysis from initial treatment to any treatment failure within 2010 to 2023

07

Study locations

1 site
  • Hospices Civils de Lyon - Hopital de la Croix Rousse - Centre de reference des infection ostéo-articulaires de Lyon
    Lyon, 69004, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06682091
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Nov 12, 2024
Start date
Jan 1, 2013
Primary completion
Jan 1, 2023
Completion
Jan 1, 2023
Last update
Nov 12, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion